Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has provided an announcement.
Shanghai MicroPort MedBot (Group) Co., Ltd. announced a change in the address of its principal place of business in Hong Kong, effective from January 10, 2025. This move signifies the company’s operational adjustments and continued commitment to maintaining its presence in a strategic location, potentially impacting its interactions with stakeholders and market positioning.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the medical technology industry and focusing on innovative medical solutions.
YTD Price Performance: -3.15%
Average Trading Volume: 11,991,553
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$9.27B
See more insights into 2252 stock on TipRanks’ Stock Analysis page.